SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB
Maria Myrthe Elisabeth Jongsma 1
Léa M. M. Costes
Irma Tindemans
Martinus A. Cozijnsen
H.C. Raatgeep
Merel van Pieterson
Yunlei Li 2
Johanna C. Escher
Lissy de Ridder
Janneke N Samsom
1 Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands
2 Erasmus MC, Rotterdam, Netherlands
Topic
Disease Mechanisms, IBD, Immunology, Paediatrics
Session
IBD prediction and prognosis
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]